Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.
- DOI
- 10.1200/jco-26-00550
- Published
- 2026 Aug 10
- Container
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1200/jco-26-00550,
title = {Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.},
author = {Eyre TA and Song Y and Hermine O and Shuang Y and Jurczak W and Farias JS and Mahuad C and Özcan M and Jachimowicz RD and Chen T and Ivanova E and Li X and Man G and Bourquelot P and Vezan R and Wang M},
year = {2026},
journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
doi = {10.1200/jco-26-00550},
url = {https://doi.org/10.1200/jco-26-00550}
}RIS
TY - JOUR TI - Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor. AU - Eyre TA AU - Song Y AU - Hermine O AU - Shuang Y AU - Jurczak W AU - Farias JS AU - Mahuad C AU - Özcan M AU - Jachimowicz RD AU - Chen T AU - Ivanova E AU - Li X AU - Man G AU - Bourquelot P AU - Vezan R AU - Wang M PY - 2026 JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology DO - 10.1200/jco-26-00550 UR - https://doi.org/10.1200/jco-26-00550 ER -
APA
TA, E., Y, S., O, H., Y, S., W, J., JS, F., C, M., M, Ö., RD, J., T, C., E, I., X, L., G, M., P, B., R, V., & M, W. (2026). Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco-26-00550
Source records
- pubmed · retrieved 2026-09-26T20:32:34.770Z